Association between certain non-small cell lung cancer driver mutations and predictive markers for chemotherapy or programmed death-ligand 1 inhibition.
Liang W, Guo M, Pan Z, Cai X, Li C, Zhao Y, Liang H, Yang H, Wang Z, Chen W, Xu C, Yang X, Sun J, He P, Gu X, Yin W, He J.
Liang W, et al. Among authors: he j, he p.
Cancer Sci. 2019 Jun;110(6):2014-2021. doi: 10.1111/cas.14032. Epub 2019 May 22.
Cancer Sci. 2019.
PMID: 31033100
Free PMC article.